These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35861597)

  • 21. Epidemiological survey of Japanese children infected with hepatitis B and C viruses.
    Iitsuka T; Murakami J; Nagata I; Kanzaki S; Shiraki K
    Hepatol Res; 2010 Sep; 40(9):878-86. PubMed ID: 20887592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nationwide cross-sectional survey on hepatitis B and C screening among workers in Japan.
    Tatemichi M; Furuya H; Nagahama S; Takaya N; Shida Y; Fukai K; Owada S; Endo H; Kinoue T; Korenaga M
    Sci Rep; 2020 Jul; 10(1):11435. PubMed ID: 32651421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011.
    Tanaka J; Akita T; Ohisa M; Sakamune K; Ko K; Uchida S; Satake M
    J Viral Hepat; 2018 Apr; 25(4):363-372. PubMed ID: 29193549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
    Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
    Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review.
    Wu D; Feng F; Wang X; Wang D; Hu Y; Yu Y; Huang J; Wang M; Dong J; Wu Y; Zhu H; Zhu F
    BMC Infect Dis; 2022 Mar; 22(1):279. PubMed ID: 35321684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing.
    Murokawa H; Yoshikawa A; Ohnuma H; Iwata A; Katoh N; Miyamoto M; Mine H; Emura H; Tadokoro K;
    Vox Sang; 2005 Jan; 88(1):10-6. PubMed ID: 15663717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data.
    Lau CS; Chen YH; Lim K; de Longueville M; Arendt C; Winthrop K
    Clin Rheumatol; 2021 Mar; 40(3):867-875. PubMed ID: 32740672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study.
    Xie J; Han Y; Qiu Z; Li Y; Li Y; Song X; Wang H; Thio CL; Li T
    J Int AIDS Soc; 2016; 19(1):20659. PubMed ID: 26979535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the treatment cascade of chronic hepatitis B and C in Greece using a telephone survey.
    Papatheodoridis G; Sypsa V; Kantzanou M; Nikolakopoulos I; Hatzakis A
    J Viral Hepat; 2015 Apr; 22(4):409-15. PubMed ID: 25209157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort.
    Ladep NG; Agaba PA; Agbaji O; Muazu A; Ugoagwu P; Imade G; Cooke G; McCormack S; Taylor-Robinson SD; Idoko J; Kanki P
    World J Gastroenterol; 2013 Mar; 19(10):1602-10. PubMed ID: 23538773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.
    Baha W; Foullous A; Dersi N; They-they TP; El alaoui K; Nourichafi N; Oukkache B; Lazar F; Benjelloun S; Ennaji MM; Elmalki A; Mifdal H; Bennani A
    BMC Public Health; 2013 Jan; 13():50. PubMed ID: 23331910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.
    Ohnuma H; Tanaka T; Yoshikawa A; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Tomono T; Murozuka T; Takeda Y; Doi Y; Mine H; Yokoyama S; Hirose T; Nishioka K;
    Microbiol Immunol; 2001; 45(9):667-72. PubMed ID: 11694079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of hepatitis B and C viruses in moderate and severe COVID-19 inpatients: A cross-sectional study at a referral center in Mexico.
    Jiménez-Mendoza JC; Rivera-López FE; González-Lara MF; Valdez-Echeverría RD; Castro-Narro GE; Tore A; Uscanga-Domínguez LF; Moctezuma-Velázquez C
    Ann Hepatol; 2022; 27(3):100684. PubMed ID: 35167956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients.
    Wiegand SB; Jaroszewicz J; Potthoff A; Höner Zu Siederdissen C; Maasoumy B; Deterding K; Manns MP; Wedemeyer H; Cornberg M
    Clin Microbiol Infect; 2015 Jul; 21(7):710.e1-9. PubMed ID: 25882360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A consensus for occupational health management of healthcare workers infected with human immunodeficiency virus, hepatitis B virus, and / or hepatitis C virus.
    Ishimaru T; Wada K; Smith DR
    J Occup Health; 2017 May; 59(3):304-308. PubMed ID: 28381816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
    PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia.
    Woldegiorgis AE; Erku W; Medhin G; Berhe N; Legesse M
    PLoS One; 2019; 14(12):e0226890. PubMed ID: 31887192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV.
    Chu CM; Yeh CT; Sheen IS; Liaw YF
    Gut; 2002 Jul; 51(1):95-9. PubMed ID: 12077099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.